2002 IR News

11.22.2002 Santen Completes Construction Work on North Building of its Nara Research and Development Center [PDF:29KB]

11.06.2002 Santen announces its financial results for the six months ended September 30, 2002 [PDF:15KB]

10.30.2002 Revision of Performance Forecasts [PDF: 21KB]

09.30.2002 Revision of Performance Forecasts [PDF:25KB]

08.23.2002 Santen to Launch OTC Eye Drops SANTE 40 [PDF:25KB]

08.21.2002 Santen Launches OPHTHAGREEN for Intravenous Injection 25mg, Fluorescein Fundus Angiography Contrast Medium [PDF:20KB]

07.05.2002 Changes to Principal Shareholder [PDF:16KB]

06.26.2002 The 90th Annual General Meeting of Shareholders was held and four items of business were resolved.